CME Group (CME) financial statements
+271.3%since 2007
- FY2025 revenue
- $6.5B▲ +6.4%
- FY2025 net income
- $4.1B▲ +15.5%
- FY2025 diluted EPS
- $11.16▲ +15.4%
- FY2025 free cash flow
- $4.2B▲ +16.6%
CME Group income statement
| USD millions | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Period ended | 31 Dec 2025 | 31 Dec 2024 | 31 Dec 2023 |
| Revenue | 6,521 | 6,130 | 5,579 |
| Operating income | 4,230 | 3,932 | 3,436 |
| Pretax income | 5,331 | 4,541 | 4,154 |
| Net income | 4,072 | 3,526 | 3,226 |
| Diluted earnings per share | 11.16 | 9.67 | 8.86 |
CME Group balance sheet
| USD millions | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Period ended | 31 Dec 2025 | 31 Dec 2024 | 31 Dec 2023 |
| Cash and cash equivalents | 4,417 | 101,794 | 2,912 |
| Total assets | 198,424 | 137,447 | 129,706 |
| Total liabilities | 169,696 | 110,960 | 102,968 |
| Total equity | 28,728 | 26,487 | 26,738 |
CME Group cash flow statement
| USD millions | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Period ended | 31 Dec 2025 | 31 Dec 2024 | 31 Dec 2023 |
| Operating cash flow | 4,277 | 3,691 | 3,454 |
| Capital expenditure | -83 | -94 | -76 |
| Free cash flow (derived) | 4,194 | 3,597 | 3,377 |
| Dividends paid | -3,933 | -3,584 | -3,235 |
Quarterly highlights
| USD millions | Q3 FY2026 | Q2 FY2026 | Q1 FY2026 | Q4 FY2025 |
|---|---|---|---|---|
| Period ended | 30 Sep 2026 | 30 Jun 2026 | 31 Mar 2026 | 31 Dec 2025 |
| Revenue (derived) | 1,737 | 1,706 | 1,880 | 1,649 |
| Operating income (derived) | 1,141 | 1,107 | 1,310 | 1,020 |
| Net income | 1,037 | 1,042 | 1,154 | n/a |
| Diluted earnings per share | 2.89 | 2.88 | 3.18 | n/a |
| Operating cash flow (derived) | 1,086 | 947 | 1,260 | 1,134 |
| Total assets | 192,093 | 194,677 | 201,994 | 198,424 |
CME Group major shareholders
| Holder | Share of class | Shares | Filed |
|---|---|---|---|
| Vanguard Capital Management | 7.5% | 27,044,709 | 29 April 2026 |
CME Group 10-K and SEC filings
| Filed | Form | Type | Description |
|---|---|---|---|
| 23 October 2026 | 10-Q | Quarterly report | Quarterly report |
| 21 October 2026 | 8-K | Current report | Current report |
| 25 September 2026 | 8-K | Current report | Current report |
| 9 September 2026 | 8-K | Current report | Current report |
| 11 August 2026 | 8-K | Current report | Current report |
| 24 July 2026 | 10-Q | Quarterly report | Quarterly report |
| 22 July 2026 | 8-K | Current report | Current report |
| 17 June 2026 | 8-K | Current report | Current report |
Common questions
What was CME Group's revenue in fiscal 2025?
CME Group reported $6.5 billion in revenue for fiscal 2025, the year ended 31 December 2025, up 6.4% from fiscal 2024.
What was CME Group's net income in fiscal 2025?
CME Group reported net income of $4.1 billion for fiscal 2025, the year ended 31 December 2025, up 15.5% from fiscal 2024. Diluted earnings per share were $11.16.
What was CME Group's free cash flow in fiscal 2025?
CME Group had $4.2 billion in free cash flow in fiscal 2025. Operating cash flow was $4.3 billion and capital expenditure was $83.5 million.
What were CME Group's total assets at the end of fiscal 2025?
CME Group reported total assets of $198.4 billion at the end of fiscal 2025, the year ended 31 December 2025.
How much CME Group history do I get?
Every account gets the full history, annual and quarterly, with first reported values and as of dates.
Start with a free key
Free $10 credits every month, no card.Free $10 credits a month, no card.